Breaking News
Get 50% Off 0
🌎 30+ NEW AI-picked stock strategies for exciting international markets
Unlock Global AI Picks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Regions Financial (RF) to Post Q4 Earnings: A Beat in Store? By Zacks Investment Research - Jan 17, 2022

Regions Financial RF is scheduled to report fourth-quarter and 2021 results on Jan 20, before the opening bell. The bank’s revenues and earnings are expected to indicate a decline from the...

3 Reasons Growth Investors Will Love ArcBest (ARCB) By Zacks Investment Research - Jan 17, 2022

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find...

Key Factors to Affect M&T Bank (MTB) This Earnings Season By Zacks Investment Research - Jan 16, 2022

M&T Bank Corporation MTB is scheduled to report fourth-quarter and 2021 results on Jan 20, before the opening bell. The company’s revenues and earnings are expected to have decreased year...

L3Harris Technologies (LHX) Wins Deal to Aid C-130H Program By Zacks Investment Research - Jan 16, 2022

L3Harris Technologies (NYSE:LHX) Inc. LHX recently secured a contract to offer program depot maintenance (PDM) for C-130H aircraft. The award has been provided by the Air Force Life Cycle Management...

U.S. Regional Banks ETF (IAT) Hits a 52-Week High By Zacks Investment Research - Jan 14, 2022

iShares U.S. Regional Banks ETF IAT is probably a suitable pick for investors looking for momentum. The fund hit a 52-week high and is up 51.9% from its 52-week low price of $45.90/share.Let’s...

U.S. Regional Banks ETF (IAT) Hits a 52-Week High By Zacks Investment Research - Jan 14, 2022

iShares U.S. Regional Banks ETF IAT is probably a suitable pick for investors looking for momentum. The fund hit a 52-week high and is up 51.9% from its 52-week low price of $45.90/share.Let’s...

TechnipFMC (FTI) to Sell Off 5% Stake in Technip Energies By Zacks Investment Research - Jan 14, 2022

Energy technology and services provider TechnipFMC (NYSE:FTI) plc FTI announced the sale of 5% of its ownership stake in Technip (PA:FTI) Energies and received gross proceeds of €118.4 million....

Banks Provide Mixed Start to Q4 Earnings Season By Zacks Investment Research - Jan 14, 2022

JPMorgan JPM and Citigroup C shares lost ground as they kick-started the Q4 earnings season for the banks. JPMorgan beat EPS estimates, but missed on revenues that were up +1.7% from the same period...

Bull of the Day: Crocs (CROX) By Zacks Investment Research - Jan 14, 2022

Crocs (NASDAQ:CROX) is a Zacks Rank #1 (Strong Buy) is a leading footwear brand with a focus on comfort and style. The name is very popular and their unique clog style is recognized all over the...

5 Defensive ETF Bets for Dealing With Fed Rate Hike Woes By Zacks Investment Research - Jan 14, 2022

Wall Street has been volatile since the beginning of 2022 as 10-year Treasury yields rose. The Federal Reserve has also hinted to take aggressive measures to manage rising inflation levels. It is...

Schlumberger (SLB) Earnings Expected to Grow: Should You Buy? By Zacks Investment Research - Jan 14, 2022

Schlumberger (NYSE:SLB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2021. This widely-known consensus outlook...

BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study By Zacks Investment Research - Jan 14, 2022

BridgeBio Pharma (NASDAQ:BBIO), Inc. BBIO announced that it has entered into a non-exclusive clinical collaboration agreement with Amgen AMGN to evaluate the combination of its investigational SHP2...

Continue with Apple
Continue with Google
or
Sign up with Email